Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
02 Apr 2014 Next Generation ALK Inhibitor for ALK-Rearranged Non–Small Cell Lung Cancer Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
01 Apr 2014 PRESTIGE Study: Goserelin Given Every 12 vs. 4 Weeks in Premenopausal Women With ER-Positive Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Mar 2014 ELCC 2014 News: Clinical Utility of miRNA Signature in Plasma of Smokers Included in LD-CT Lung Cancer Screening Cancer prevention - Translational research - Lung and other thoracic tumours
27 Mar 2014 ELCC 2014 News: Mutational Spectrum of Patients Enrolled Into GALAXY-1 Study Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Efficacy and Safety of Targeted Therapy in Elderly Patients With Lung Cancer Adenocarcinoma Cancer in Special Situations - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: PD-L1 Expression and Association with Survival in Mesothelioma Pathology/Molecular biology - Lung and other thoracic tumours - Immuno-oncology
27 Mar 2014 ELCC 2014 News: PD-L1 and PD-1 Expression in a Cohort of Molecularly Selected NSCLC Patients Pathology/Molecular biology - Lung and other thoracic tumours - Immuno-oncology
27 Mar 2014 ELCC 2014 News: Diagnosis and Targeting Lung Adenocarcinoma with RET Fusion Pathology/Molecular biology - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: QoL in ENSURE Study of First-Line Erlotinib vs. Gemcitabine/Cisplatin in Asian Patients with EGFR Mutation-Positive NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Phase I Study of CO-1686 in Patients with EGFR Mutated Recurrent, Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
24 Mar 2014 EMA Recommends Granting a Conditional Marketing Authorisation for Vintafolide for the Treatment of Platinum-resistant Ovarian Cancer that Expresses the Folate Receptor Personalised medicine - Gynaecologic malignancies - Anticancer agents & Biologic therapy
20 Mar 2014 Precision Oncology 3.0 Personalised medicine
20 Mar 2014 Coordinating Action Systems Medicine: Systems Biology Application Across Europe Personalised medicine
19 Mar 2014 Idelalisib in Relapsed Indolent Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
18 Mar 2014 2013: A Year of Progress in Oncology Breast cancer - Melanoma - Lung and other thoracic tumours - Gynaecologic malignancies - Gastrointestinal cancers - Anticancer agents & Biologic therapy